CD8A and melanoma: Anti-tumor therapy against HCC was not observed if the VSV-cDNA was derived from melanoma instead of HCC tumors, was dependent upon CD8+ but less so on CD4+ T cells and was associated with a Th17 phenotype of T cell activity (Fig. 7).